Evidence map›Paper›PMID 39257296›Full record

ArticleAmerican journal of medical genetics. Part A2025

Aortic Root Dilation and Genotype Associations in Phelan-McDermid Syndrome.

Jake Gluckman, Tess Levy, Kate Friedman, Francesca Garces, Rajna Filip-Dhima, Aisling Quinlan, Isabelle Iannotti, Margaret Pekar, Alexandra Lopez Hernandez, Madison T Nava and 13 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jake GluckmanSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-2506-7319
Tess LevySeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kate FriedmanSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Francesca GarcesSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Rajna Filip-DhimaDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Aisling QuinlanDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Isabelle IannottiDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Margaret PekarNeurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
Alexandra Lopez HernandezDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois, USA.
Madison T NavaDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois, USA.
Elijah KravetsDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Abigail SiegelSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jonathan A BernsteinDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0001-5369-346X
Elizabeth Berry-KravisDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois, USA.
Craig M PowellDepartment of Neurobiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Latha Valluripalli SooryaDepartment of Psychiatry & Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Audrey ThurmNeurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
Siddharth SrivastavaDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-7008-1879
Joseph D BuxbaumSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mustafa SahinDepartment of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Alexander KolevzonSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Bruce D GelbThe Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0001-8527-5027
Developmental Synaptopathies Consortium

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Maurizio Macaluso, Michael Wagner · 2019 to 2026
$51.2M
Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI M. Pilar Trelles · 2014 to 2026
$20.1M
Neurodevelopmental and Behavioral Phenotyping ZICMH002961 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI THURM, AUDREY · 2017 to 2025
$12.6M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic AutismR01NS105845 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOLEVZON, ALEXANDER · 2018 to 2022
$3.7M
Investigating the Genetic Landscape of Cerebral PalsyK23NS119666 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI SRIVASTAVA, SIDDHARTH · 2021 to 2025
$1.1M
Intramural NIH HHS ZIC MH002961NCATS NIH HHS U2C TR002818NICHD NIH HHS P50 HD105351NIH HHS K23NS119666NIMH Intramural Research Program ZICMH002961NINDS NIH HHS K23 NS119666NINDS NIH HHS R01 NS105845NINDS NIH HHS U54 NS092090Rare Diseases Clinical Research NetworkRDCRN Data Management and Coordinating Center (DMCC) U2CTR002818The Developmental Synaptopathies Consortium U54NS092090
6 · The paper itself

Abstract

Phelan-McDermid syndrome (PMS) is a rare genetic neurodevelopmental disorder that results from the loss of one functional copy of the SHANK3 gene. While many clinical features of PMS are well-understood, there is currently limited literature on cardiovascular abnormalities in PMS. This report aims to evaluate the prevalence of aortic root dilation (ARD) among individuals with PMS and to understand if underlying genetic variation relates to risk for ARD. We present findings from 59 participants collected from a multisite observational study evaluating the phenotype and natural history of PMS. Individual echocardiographic and genetic reports were analyzed for aortic root measurements and genetic variant data, respectively. Our a priori hypothesis was that participants with chromosome 22 deletions with hg19 start coordinates on or before 49,900,000 (larger deletions) would have more instances of ARD than participants with deletion start coordinates after 49,900,000 (smaller deletions). Eight participants (14%) had ARD, and its presence was statistically significantly associated with large deletions (p = 0.047). Relatedly, participants with ARD had significantly more genes deleted on chromosome 22 than participants without ARD (p = 0.013). These results could aid in the identification of individuals with PMS who are at higher risk for ARD.

Indexed as

Chromosome DeletionChromosome DisordersChromosomes, Human, Pair 22AdolescentAdultAortaChildChild, PreschoolEchocardiographyFemaleGenetic Association StudiesGenotypeHumansMaleNerve Tissue ProteinsPhenotypeNerve Tissue ProteinsSHANK3 protein, human22q13aortic root dilationgenotype–phenotype correlationPhelan‐McDermid syndromeSHANK3

Identifiers

PMID39257296
PMCPMC11637948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.